Key result
Oral indomethacin and ibuprofen achieve similar ~90% PDA closure rates in preterm neonates.
Why the study?
The study aimed to evaluate the clinical profile of preterm neonates with patent ductus arteriosus and the outcome of medical management in ductal closure.
Observational (n=107)
No
Answers are grounded in this paper and cite their sources.
Observational data on oral indomethacin or ibuprofen for PDA closure in preterm neonates; leaves open the need for randomized trials before practice change.
Objective and design: Prospective study 1. To study the clinical profile of neonates with PDA 2. Outcome of medical management in closure of ductus arteriosus. Setting: NICU of a tertiary care centre at Ahmedabad Subjects and intervention: All preterm neonates from October 2012 to September 2013, clinically diagnosed to have PDA were confirmed by 2D ECHO. The clinical profile of these neonates was studied. Those with haemo-dynamically significant PDA were given oral Indomethacin or Ibuprofen according to their clinical condition. Results: In 12 months, 107 preterm neonates had ECHO proven PDA. 80% had hemo-dynamically significant PDA. HMD(37.4%) and septicaemia(33.6%) were most common morbidities associated. Closure rate after medical treatment were 90% in Indomethacin and 88% in Ibuprofen group. Conclusion: High index of suspicion for PDA, early diagnosis and timely intervention can achieve good neonatal outcome. Medical therapy can achieve closure in most of the neonates.
No takes yet. Share an insight, caveat, or question.
Vohra et al. (2012) conducted an observational in Patent ductus arteriosus in preterm neonates (n=107). Oral indomethacin vs. Oral ibuprofen was evaluated on Closure rate of hemodynamically significant patent ductus arteriosus after medical treatment. Oral indomethacin and ibuprofen achieved patent ductus arteriosus closure in 90% and 88% of preterm neonates with hemodynamically significant PDA, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: